<DOC>
	<DOC>NCT00626184</DOC>
	<brief_summary>To assess safety and tolerability of ALV003 in healthy volunteers and patients with Celiac Disease</brief_summary>
	<brief_title>A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease</brief_title>
	<detailed_description>A Phase 1, Two Stage, Single Dose, Single-Blind, Placebo Controlled, Dose Escalation, Crossover Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease</detailed_description>
	<mesh_term>Celiac Disease</mesh_term>
	<criteria>INCLUSION Health Status 1. Healthy volunteers must be in good health 2. Celiac Disease must be well controlled and in good health Either male or nonlactating, nonpregnant females who are postmenopausal, sterile or using at least two acceptable and highly effective birth control methods. Body Mass Index (BMI) of &lt; 30 kg/m2, EXCLUSION A positive urine test for alcohol or illegal drugs at screening. The subject has received an experimental drug within 30 days of the present study. History of substance abuse, within the last 5 years Clinically significant abnormal lab values, as determined by the PI Alcohol consumption of &gt; 2 standard drinks equivalents per day12. Positive pregnancy test within 7 days prior to study drug administration. history of any medically significant condition considered by the PI to adversely affect participation in the trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Celiac Disease</keyword>
</DOC>